BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25013626)

  • 1. Cytomegalovirus Infection following Kidney Transplantation: a Multicenter Study of 3065 Cases.
    Einollahi B
    Int J Organ Transplant Med; 2012; 3(2):74-8. PubMed ID: 25013626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience.
    Selvey LA; Lim WH; Boan P; Swaminathan R; Slimings C; Harrison AE; Chakera A
    BMC Infect Dis; 2017 Jul; 17(1):501. PubMed ID: 28716027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
    Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
    BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Leukocyte Antigen Alleles and Cytomegalovirus Infection After Renal Transplantation.
    Futohi F; Saber A; Nemati E; Einollahi B; Rostami Z
    Nephrourol Mon; 2015 Nov; 7(6):e31635. PubMed ID: 26866009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney transplantation from related and unrelated living donors in a single German centre.
    Voiculescu A; Ivens K; Hetzel GR; Hollenbeck M; Sandmann W; Grabitz K; Balzer K; Schneider F; Grabensee B
    Nephrol Dial Transplant; 2003 Feb; 18(2):418-25. PubMed ID: 12543901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus as a risk factor in living-related renal transplantation. A prospective study.
    Pollak R; Barber PL; Prusak BF; Mozes MF
    Ann Surg; 1987 Mar; 205(3):302-4. PubMed ID: 3030201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection and graft rejection in renal transplantation.
    Dickenmann MJ; Cathomas G; Steiger J; Mihatsch MJ; Thiel G; Tamm M
    Transplantation; 2001 Mar; 71(6):764-7. PubMed ID: 11330539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living unrelated donors in kidney transplants: better long-term results than with non-HLA-identical living related donors?
    Humar A; Durand B; Gillingham K; Payne WD; Sutherland DE; Matas AJ
    Transplantation; 2000 May; 69(9):1942-5. PubMed ID: 10830235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
    Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of kidney transplant tourism in children: a single center experience.
    Majid A; Al Khalidi L; Ahmed BQ; Opelz G; Schaefer F
    Pediatr Nephrol; 2010 Jan; 25(1):155-9. PubMed ID: 19727837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Risk Factors for Cytomegalovirus Infection in Patients With Kidney Transplantation: A Single-Center Experience.
    Feng S; Yang J; Wang W; Hu X; Liu H; Qian X; Feng D; Zhang X
    Transplant Proc; 2016 Oct; 48(8):2695-2699. PubMed ID: 27788803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
    Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
    Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus Infection after Renal Transplantation: Occurrence, Clinical Features, and the Cutoff for Antigenemia in a University Hospital in Brazil.
    de Matos SB; Meyer R; Lima FWM
    Infect Chemother; 2017 Dec; 49(4):255-261. PubMed ID: 29299892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of cytomegalovirus infection after pancreas transplantation.
    Parsaik AK; Bhalla T; Dong M; Rostambeigi N; Dierkhising RA; Dean P; Abraham R; Prieto M; Kremers WK; Razonable RR; Kudva YC
    Transplantation; 2011 Nov; 92(9):1044-50. PubMed ID: 21904269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients.
    Doesch AO; Repp J; Hofmann N; Erbel C; Frankenstein L; Gleissner CA; Schmidt C; Ruhparwar A; Zugck C; Schnitzler P; Ehlermann P; Dengler TJ; Katus HA
    Drug Des Devel Ther; 2012; 6():289-95. PubMed ID: 23091373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients.
    Wirgart BZ; Claesson K; Eriksson BM; Brundin M; Tufveson G; Tötterman T; Grillner L
    Clin Diagn Virol; 1996 Nov; 7(2):99-110. PubMed ID: 9137866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
    Boeckh M; Bowden RA; Storer B; Chao NJ; Spielberger R; Tierney DK; Gallez-Hawkins G; Cunningham T; Blume KG; Levitt D; Zaia JA
    Biol Blood Marrow Transplant; 2001; 7(6):343-51. PubMed ID: 11464977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovir.
    Turgeon N; Fishman JA; Doran M; Basgoz N; Tolkoff-Rubin NE; Cosimi AB; Rubin RH
    Transpl Infect Dis; 2000 Mar; 2(1):2-10. PubMed ID: 11429003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Cytomegalovirus Serostatus on Allograft Loss and Mortality Within the First Year After Kidney Transplantation: An Analysis of the National Transplant Registry.
    Bruminhent J; Dajsakdipon T; Ingsathit A; Supaporn T; Prommool S; Watcharananan SP
    Transplant Proc; 2020 Apr; 52(3):829-835. PubMed ID: 32113693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy.
    Harvala H; Stewart C; Muller K; Burns S; Marson L; MacGilchrist A; Johannessen I
    J Med Virol; 2013 May; 85(5):893-8. PubMed ID: 23508914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.